Your browser doesn't support javascript.
loading
Measuring intolerance to mutation in human genetics.
Fuller, Zachary L; Berg, Jeremy J; Mostafavi, Hakhamanesh; Sella, Guy; Przeworski, Molly.
Afiliação
  • Fuller ZL; Department of Biological Sciences, Columbia University, New York, NY, USA. zlf2101@columbia.edu.
  • Berg JJ; Department of Biological Sciences, Columbia University, New York, NY, USA.
  • Mostafavi H; Department of Biological Sciences, Columbia University, New York, NY, USA.
  • Sella G; Department of Biological Sciences, Columbia University, New York, NY, USA.
  • Przeworski M; Department of Systems Biology, Columbia University, New York, NY, USA.
Nat Genet ; 51(5): 772-776, 2019 05.
Article em En | MEDLINE | ID: mdl-30962618
In numerous applications, from working with animal models to mapping the genetic basis of human disease susceptibility, knowing whether a single disrupting mutation in a gene is likely to be deleterious is useful. With this goal in mind, a number of measures have been developed to identify genes in which protein-truncating variants (PTVs), or other types of mutations, are absent or kept at very low frequency in large population samples-genes that appear 'intolerant' to mutation. One measure in particular, the probability of being loss-of-function intolerant (pLI), has been widely adopted. This measure was designed to classify genes into three categories, null, recessive and haploinsufficient, on the basis of the contrast between observed and expected numbers of PTVs. Such population-genetic approaches can be useful in many applications. As we clarify, however, they reflect the strength of selection acting on heterozygotes and not dominance or haploinsufficiency.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article